CDCA3 and cancer: Should the complement cascade override the effects of CD55 (and CD46, another mCRP) and manage to activate the terminal complement components on cancer cell membranes, functional CD59 molecules bind to human C8 and C9, during the attempt to properly assemble the membrane attack complex [31].